GSK3B and Alzheimer disease: Despite changes in ERα content, ERK, and Akt signaling affecting the AB-OVX group, differences in downstream targets p-GSK-3β, pSer396-Tau, or IDE were not significant nor was the longer, more hydrophobic and AD-related Aβ(1–42) peptide detected consistently.